发明名称 |
CRYSTALLINE [R-(R*R*)] - 2 - (4 - FLUOROPHENYL) - ??, Ó¬á - DELTA-DIHYDROXY - 5 - (1 - METHYLETHYL) - 3 - PHENYL - 4 - (PHENYLAMINO) CARBONYL] - 1H - PYRROLE - 1 - HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN)HYDRATE |
摘要 |
There are described novel crystalline forms of ÄR-(R*,R*)Ü-2-(4-fluorophenyl)- beta , delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-Ä(phenylamino)carbonylÜ-1H-pyr role-l-heptanoic acid hemi calcium salt designated Form II and Form IV which are characterized by their X-ray powder diffraction and/or solid state NMR, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia and hypercholesterolemia. |
申请公布号 |
IL128862(A) |
申请公布日期 |
2007.12.03 |
申请号 |
IL19960128862 |
申请日期 |
1996.07.08 |
申请人 |
WARNER-LAMBERT COMPANY LLC |
发明人 |
|
分类号 |
C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D |
主分类号 |
C07D207/34 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|